Blog

Careers

Advertise

Contact

logo
  • About
    • Mission
    • What Is A GPO ?
    • Policy Positions
    • HSCA Committees
    • Member Organizations
    • FAQ
    • Leadership
    • HSCA Staff
    • Contact
  • Events
    • National Pharmacy Forum 2022
    • Past Events
  • CHeS
    • CHeS Total Visibility Project
    • CHeS Membership
    • CHeS Resources
  • Issues
  • Resources
    • Studies
    • Hospital Testimonials
    • Supplier Endorsements
    • Small Supplier Portal
    • Congressional Resources
    • COVID-19 Recommendations
    • COVID-19 Response Efforts
  • News
  • About
    • Mission
    • What Is A GPO ?
    • Policy Positions
    • HSCA Committees
    • Member Organizations
    • FAQ
    • Leadership
    • HSCA Staff
    • Contact
  • Events
    • National Pharmacy Forum 2022
    • Past Events
  • CHeS
    • CHeS Total Visibility Project
    • CHeS Membership
    • CHeS Resources
  • Issues
  • Resources
    • Studies
    • Hospital Testimonials
    • Supplier Endorsements
    • Small Supplier Portal
    • Congressional Resources
    • COVID-19 Recommendations
    • COVID-19 Response Efforts
  • News

HSCA Support Letter to the House Committee on Energy & Commerce on House Passage of FDA User Fee Reauthorizations

June 30, 2022 by Grace Crozier Uncategorized 0 comments

On behalf of the Healthcare Supply Chain Association (HSCA), which represents the nation’s leading healthcare group purchasing organizations (GPOs), we applaud the bipartisan leadership of Chairman Pallone, Chairwoman Eshoo, Ranking Member Rodgers, and Ranking Member Guthrie of the House Committee on Energy & Commerce on the Food and Drug Amendments Act of 2022, which the House of Representatives recently passed with overwhelming support by a vote of 392-28. Timely access to safe and effective drugs, devices, products, and biologics for all Americans is of critical importance to GPOs, which serve as the sourcing partners to virtually all hospitals, clinics, ambulatory surgery centers, and long-term care facilities.

 

Click here to read the full letter.

Prev

Related Posts

HSCA Applauds House Judiciary Committee for Advancing the CREATES Act
April 30, 2019

Washington, DC (April 30, 2019) – Healthcare Supply Chain Association (HSCA)...

Learn more
HSCA Support Letter to the House Committee on Energy & Commerce on House Passage of FDA User Fee Reauthorizations
June 30, 2022

On behalf of the Healthcare Supply Chain Association (HSCA), which represents the...

Learn more
HSCA Applauds Senators Collins and Smith for Bipartisan Legislation to Prevent and Mitigate Drug Shortages
October 30, 2019

Washington, DC (October 30, 2019) – Healthcare Supply Chain Association (HSCA)...

Learn more
HSCA Comments to FDA Regarding FDA’s List of Public Health Focused Essential Medicines
February 5, 2021

On behalf of the Healthcare Supply Chain Association (HSCA), we appreciate the...

Learn more

Our Office

Healthcare Supply Chain Association
1341 G Street NW Suite 600
Washington, DC 20005

Phone: 202.629.5833
Fax: 202.466.9666
Email: info@supplychainassociation.org

LATEST NEWS

  • HSCA Support Letter to the House Committee on Energy & Commerce on House Passage of FDA User Fee Reauthorizations
    June 30, 2022
  • ANALYSIS: GPOs Helped Increase Domestic Manufacturing Capacity, Protected Hospitals and Patients from Thousands of Fraudulent Sellers, and Helped Identify and Bring New Suppliers to Market to Avert Supply and Drug Shortages During COVID-19
    April 20, 2022